Qualified Participants Must:
Have 2 to 8 migraines a month (lasting 4 hours or more)
Qualified Participants May Receive:
The investigational drug, plus all study-related assessments, will be provided at no cost to you. Health insurance is not required to take part in this study and compensation for travel may also be provided.